8. Use In Specific Populations 8.1 Pregnancy Risk Summary There are no adequate data on the developmental risk associated with the use of NAMENDA in pregnant women. Adverse developmental effects (decreased body weight, and skeletal ossification) were observed in the offspring of rats administered ...
The product information provided in this site is intended only for consumers in the United States. The products discussed on this site may have different product labeling outside of the United States. The health information described on this site is provided for educational purposes only ...
Memantine's effects are independent of acetylcholine and acetylcholinesterase. Glutamate is the main excitatory neurotransmitter in the brain. It is believed that too much stimulation of nerve cells by glutamate may be responsible for the degeneration of nerves that occurs in some neurological diseases s...
heart disease,fainting, seizures, GI diseases or urinary problems because they may get worst with this drug. Aricept is not recommended for use in pregnant or breastfeeding women. Aricept safety and effectiveness has not been studied in the pediatric population....
8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy Pregnancy Category B There are no adequate and well-controlled studies of memantine in pregnant women. NAMENDA should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Memantine given orally to pregnant rats...
namenda(memantinehcl)处方使用指导.pdf,NAMENDA - memantine hydrochloride tablet NAMENDA - memantine hydrochloride s olution NAMENDA - memantine hydrochloride Fores t Laboratories , Inc. HI GHLI GHT OF PRE CRIBING INFORMAT I ON T he se hig hlig hts do no t